Tobira Therapeutics Revenue, Growth & Competitor Profile

DBA REGADO BIOSCIENCES, INC.

Company Profile & Annual Report for Tobira Therapeutics

Access the complete profile.

Tobira Therapeutics Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	701 Gateway Blvd. Suite 300 S. San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Tobira Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tobira Therapeutics's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Tobira Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Trademark Applications

Trademark applications show the products and services that Tobira Therapeutics is developing and marketing. Tobira Therapeutics doesn't have any recent trademark applications, indicating Tobira Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
S Pharmaceutical research and development	06/02/2014
REGADO Pharmaceutical preparations for the treatment of cardiovascular disease, peripheral vascular disease and blood coagulation disorders	05/14/2013
TOBIRA [House mark for a line of ] pharmaceutical preparations for the treatment and/or prevention of HIV/AIDS, [ hepatitis] and other infectious diseases, but excluding respiratory diseases	04/10/2008

See all trademarks and details in the Full Report.

Market Share of Tobira Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tobira Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Tobira Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GENENTECH	South San Francisco, CA	100
IGM BIOSCIENCES	Mountain View, CA	1
AKASA	South San Francisco, CA	1
MYOKARDIA	South San Francisco, CA	1
KRIYA THERAPEUTICS	Redwood City, CA	1
EPICRISPR BIOTECHNOLOGIES	South San Francisco, CA	1

Future Competition: Tobira Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Tobira Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)